Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
Business Summary
Number of employees: 10
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Canada
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,325 | 0 | 0 | 92.40 % |
Stock B | 1 | 163,201,977 | 150,799,507 ( 92.40 %) | 0 | |
Stock C | 0 | 467,188 | 0 | 0 |
Company contact information
InNexus Biotechnology, Inc.
1500 Royal Centre 1055 West Georgia Street
V6E 4N7, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 154 | |
+11.91% | 12TCr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-10.12% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr |
- Stock Market
- Equities
- IXSBF Stock
- Company InNexus Biotechnology, Inc.